Merve Sahin

Massive Bio Launches ‘I Have Cancer’ Campaign

November 17, 2022

Massive Bio Launches ‘I Have Cancer’ Campaign

November 17th 2022: Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, launches "I Have Cancer," a social media campaign to raise cancer awareness.  In ...
Massive Bio Publishes the Second Issue of Massive Bio magazine

November 02, 2022

Massive Bio Publishes the Second Issue of Massive Bio magazine

November 2nd, 2022:  Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut i...
Massive Bio plans acquisitions with Series B round

June 27, 2022

Massive Bio plans acquisitions with Series B round

Massive Bio, a New York-based company with an AI tool that matches cancer patients with clinical trials appropriate to their cancer diagnosis, is planning bolt-on acquisitions following a Series B...